subject: CHEBI:85078

object_name: Prediabetes


subject: CHEBI:6950

subject_name: Mirtazapine

object_name: Presenile dementia

tested_intervention: yes


subject: CHEBI:6950

object_name: dementia


subject: CHEMBL.COMPOUND:CHEMBL4297858

subject_name: BUDIGALIMAB

object_name: esophageal adenocarcinoma

tested_intervention: unsure


subject: CHEMBL.COMPOUND:CHEMBL4297858


subject: UMLS:C4527193


subject: UMLS:C4527193


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UNII:CVX52RV2DC

subject_name: TELISOTUZUMAB ADIZUTECAN


subject: UNII:CVX52RV2DC


subject: PUBCHEM.COMPOUND:86821

object_name: Hypercholesterolemia


subject: PUBCHEM.COMPOUND:86821

object_name: aneurysm


subject: CHEBI:26125

subject_name: phytosterols


subject: CHEBI:26125


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL


subject: CHEMBL.COMPOUND:CHEMBL3833369


subject: CHEBI:30021

subject_name: Selenomethionine

object_name: prostate carcinoma


subject: CHEBI:30021

object_name: prostate cancer


subject: UMLS:C1517683

subject_name: L-Selenomethionine


subject: UMLS:C1517683


subject: UNII:8ZHS5657EH

subject_name: Tagraxofusp

object_name: myelofibrosis


subject: UNII:8ZHS5657EH

object_name: acute myeloid leukemia by FAB classification


subject: UNII:8ZHS5657EH

object_name: acute myeloid leukemia


subject: UNII:8ZHS5657EH

object_name: juvenile myelomonocytic leukemia


subject: UNII:8ZHS5657EH

object_name: chronic myelomonocytic leukemia


subject: UMLS:C1831974


subject: UMLS:C1831974


subject: UMLS:C1831974


subject: UMLS:C1831974


subject: UMLS:C1831974


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: epilepsy


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: peritoneum cancer


subject: CHEBI:45863

object_name: ovarian cancer


subject: CHEBI:45863

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:92994

subject_name: ambroxol

object_name: Gaucher disease type I


subject: CHEBI:92994

object_name: Gaucher disease


subject: CHEBI:135590

subject_name: Ambroxol


subject: CHEBI:135590


subject: UMLS:C0718247

subject_name: Active brand of pseudoephedrine-triprolidine

object_name: Depressed mood


subject: UMLS:C0718247

object_name: Cancer patients and suicide and depression


subject: UMLS:C0718247

object_name: Depressed - symptom


subject: UMLS:C0718247

object_name: Depression, CTCAE


subject: CHEBI:24536

subject_name: Pepsin

object_name: dyspepsia


subject: CHEBI:24536

object_name: Dyspepsia, CTCAE


subject: CHEBI:24536

object_name: functional gastric disease


subject: CHEBI:24536

object_name: Abdominal pain


subject: CHEBI:24536

object_name: Abdominal Pain, CTCAE


subject: CHEBI:24536

object_name: Flatulence


subject: CHEBI:24536

object_name: Flatulence, CTCAE


subject: CHEBI:24536

object_name: Vomiting, CTCAE


subject: CHEBI:24536

object_name: Vomiting


subject: CHEBI:24536

object_name: Nausea, CTCAE_5


subject: CHEBI:24536

object_name: Nausea


subject: CHEBI:24536

object_name: Nausea, CTCAE_3


subject: UNII:GID333S43J

subject_name: PEPSIN


subject: UNII:GID333S43J


subject: UNII:GID333S43J


subject: UNII:GID333S43J


subject: UNII:GID333S43J


subject: UNII:GID333S43J


subject: UNII:GID333S43J


subject: UNII:GID333S43J


subject: UNII:GID333S43J


subject: UNII:GID333S43J


subject: UNII:GID333S43J


subject: UNII:GID333S43J


subject: UMLS:C0030909

subject_name: pepsin A


subject: UMLS:C0030909


subject: UMLS:C0030909


subject: UMLS:C0030909


subject: UMLS:C0030909


subject: UMLS:C0030909


subject: UMLS:C0030909


subject: UMLS:C0030909


subject: UMLS:C0030909


subject: UMLS:C0030909


subject: UMLS:C0030909


subject: UMLS:C0030909


subject: UMLS:C3490330

subject_name: HPN 100

object_name: urea cycle disorder


subject: CHEBI:134745

subject_name: Glycerol phenylbutyrate


subject: HMDB:HMDB0255955

object_name: Immune System Finding


subject: CHEBI:7754

subject_name: oligonucleotide


subject: PUBCHEM.COMPOUND:167253

subject_name: Phosphorothioate


subject: CHEBI:27928

subject_name: parathion


subject: UMLS:C0599533

subject_name: phosphorothioate


subject: GTOPDB:8965

subject_name: fasinumab

object_name: osteoarthritis, knee


subject: GTOPDB:8965

object_name: osteoarthritis, hip


subject: CHEMBL.COMPOUND:CHEMBL2109528

subject_name: FASINUMAB


subject: CHEMBL.COMPOUND:CHEMBL2109528


subject: UMLS:C4519593


subject: UMLS:C4519593


subject: UMLS:C0140281

subject_name: retinoic acid receptor gamma

object_name: emphysema


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: T-cell large granular lymphocyte leukemia


subject: UNII:3JB47N2Q2P

subject_name: Natalizumab

object_name: multiple sclerosis


subject: UMLS:C0665297

subject_name: natalizumab


subject: UMLS:C0697999

subject_name: isosorbide mononitrate 60 MG Extended Release Oral Tablet [Imdur]

object_name: Headache


subject: UMLS:C0697999

object_name: Headache, CTCAE


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: prostate carcinoma


subject: UNII:4F4X42SYQ6

object_name: prostate cancer


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: CHEMBL.COMPOUND:CHEMBL4594340

subject_name: POSOLEUCEL

object_name: hemorrhagic cystitis


subject: CHEMBL.COMPOUND:CHEMBL4594340

object_name: BK virus infection


subject: CHEBI:149504

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:149504

object_name: glioblastoma


subject: CHEBI:149504

object_name: Childhood Glioblastoma


subject: CHEBI:149504

object_name: adult glioblastoma


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:6541


subject: UNII:7NL2E3F6K3

subject_name: Emicizumab

object_name: von Willebrand disease 3


subject: CHEBI:95044

subject_name: Tosedostat

object_name: pancreatic neoplasm


subject: CHEBI:95044

object_name: exocrine pancreatic carcinoma


subject: CHEBI:95044

object_name: malignant pancreatic neoplasm


subject: MESH:D000084922

subject_name: Resistant Starch

object_name: Prediabetes


subject: CHEBI:38940

subject_name: Sunitinib

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:38940

object_name: clear cell renal carcinoma


subject: CHEBI:38940

object_name: renal cell adenocarcinoma


subject: CHEBI:38940

object_name: Stage IV Renal Cell Cancer


subject: CHEBI:38940

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:38940

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: CHEBI:38940

object_name: Stage III Renal Cell Cancer AJCC v8


subject: CHEBI:38940

object_name: Stage III renal cell cancer


subject: CHEBI:38940

object_name: Stage III Renal Cell Cancer AJCC v7


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: multiple organ dysfunction syndrome


subject: CHEBI:6888

object_name: adult acute respiratory distress syndrome


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Metastatic Cutaneous Melanoma


subject: UNII:DPT0O3T46P

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UNII:DPT0O3T46P

object_name: metastatic melanoma


subject: UNII:DPT0O3T46P

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: UNII:DPT0O3T46P

object_name: Unresectable Malignant Neoplasm


subject: UMLS:C0354604

subject_name: oral anticoagulants

object_name: Adverse drug response


subject: CHEBI:7565

subject_name: Nifedipine

object_name: Iron Overload


subject: CHEBI:7565

object_name: iron poisoning


subject: CHEBI:7565

object_name: Iron Overload, CTCAE


subject: CHEBI:7565

object_name: hemochromatosis


subject: CHEBI:7565

object_name: hemosiderosis


subject: CHEBI:7565

object_name: hemochromatosis type 1


subject: CHEBI:7565

object_name: thalassemia


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Parkinson disease


subject: MESH:C000656575

object_name: acute myeloid leukemia by FAB classification


subject: MESH:C000656575

object_name: acute myeloid leukemia


subject: MESH:C000656575

object_name: acute lymphoblastic leukemia


subject: CHEBI:41423

subject_name: Celecoxib

object_name: lung cancer


subject: CHEBI:41423

object_name: lung neoplasm


subject: CHEBI:41423

object_name: lung carcinoma


subject: CHEBI:95165

object_name: Accelerated Phase Myeloproliferative Neoplasm


subject: CHEBI:95165

object_name: Blast Phase Myeloproliferative Neoplasm


subject: CHEBI:95165


subject: CHEBI:95165

object_name: Myelofibrosis due to another disorder


subject: CHEBI:95165

object_name: essential thrombocythemia


subject: CHEBI:95165

object_name: acquired polycythemia vera


subject: CHEBI:95165

object_name: myelofibrosis


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: UNII:39IS23Q1EW

subject_name: Cedazuridine


subject: UNII:39IS23Q1EW


subject: UNII:39IS23Q1EW


subject: UNII:39IS23Q1EW


subject: UNII:39IS23Q1EW


subject: UNII:39IS23Q1EW


subject: UNII:39IS23Q1EW


subject: UNII:XC0UT08SNJ


subject: UNII:XC0UT08SNJ


subject: UNII:XC0UT08SNJ


subject: UNII:XC0UT08SNJ


subject: UNII:XC0UT08SNJ


subject: UNII:XC0UT08SNJ


subject: UNII:XC0UT08SNJ


subject: UNII:54T74394F8

subject_name: IADADEMSTAT


subject: UNII:54T74394F8


subject: UNII:54T74394F8


subject: UNII:54T74394F8


subject: UNII:54T74394F8


subject: UNII:54T74394F8


subject: UNII:54T74394F8


subject: MESH:C000730035

subject_name: iadademstat


subject: MESH:C000730035


subject: MESH:C000730035


subject: MESH:C000730035


subject: MESH:C000730035


subject: MESH:C000730035


subject: MESH:C000730035


subject: CHEBI:8707

subject_name: Quetiapine

object_name: schizophrenia


subject: UMLS:C2830049

object_name: Fatigue, CTCAE 5.0


subject: UMLS:C2830049

object_name: Fatigue


subject: UMLS:C2830049

object_name: Cachexia


subject: UMLS:C2830049

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:5466794

subject_name: Flavopiridol

object_name: Untreated Adult Acute Myeloid Leukemia


subject: PUBCHEM.COMPOUND:5466794

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: PUBCHEM.COMPOUND:5466794

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: PUBCHEM.COMPOUND:5466794

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: PUBCHEM.COMPOUND:5466794

object_name: adult acute myeloid leukemia with del(5q)


subject: PUBCHEM.COMPOUND:5466794

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: PUBCHEM.COMPOUND:5466794

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: PUBCHEM.COMPOUND:5466794

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: PUBCHEM.COMPOUND:5466794

object_name: Adult Acute Myelomonocytic Leukemia


subject: PUBCHEM.COMPOUND:5466794

object_name: Adult Pure Erythroid Leukemia


subject: PUBCHEM.COMPOUND:5466794

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: PUBCHEM.COMPOUND:5466794

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:5466794

object_name: adult acute monocytic leukemia


subject: PUBCHEM.COMPOUND:5466794

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: PUBCHEM.COMPOUND:5466794

object_name: Adult Acute Monoblastic Leukemia


subject: PUBCHEM.COMPOUND:5466794

object_name: Adult Erythroleukemia


subject: PUBCHEM.COMPOUND:5466794

object_name: acute megakaryoblastic leukemia in adult


subject: CHEBI:47344

subject_name: Alvocidib

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:47344

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:47344

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:47344

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:47344

object_name: adult acute myeloid leukemia with del(5q)


subject: CHEBI:47344

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:47344

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: CHEBI:47344

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:47344

object_name: Adult Acute Myelomonocytic Leukemia


subject: CHEBI:47344

object_name: Adult Pure Erythroid Leukemia


subject: CHEBI:47344

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: CHEBI:47344

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: CHEBI:47344

object_name: adult acute monocytic leukemia


subject: CHEBI:47344

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: CHEBI:47344

object_name: Adult Acute Monoblastic Leukemia


subject: CHEBI:47344

object_name: Adult Erythroleukemia


subject: CHEBI:47344

object_name: acute megakaryoblastic leukemia in adult


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: PUBCHEM.COMPOUND:5458171

subject_name: MITOXANTRONE HYDROCHLORIDE

object_name: Untreated Adult Acute Myeloid Leukemia


subject: PUBCHEM.COMPOUND:5458171

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: PUBCHEM.COMPOUND:5458171

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: PUBCHEM.COMPOUND:5458171

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: PUBCHEM.COMPOUND:5458171

object_name: adult acute myeloid leukemia with del(5q)


subject: PUBCHEM.COMPOUND:5458171

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: PUBCHEM.COMPOUND:5458171

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: PUBCHEM.COMPOUND:5458171

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: PUBCHEM.COMPOUND:5458171

object_name: Adult Acute Myelomonocytic Leukemia


subject: PUBCHEM.COMPOUND:5458171

object_name: Adult Pure Erythroid Leukemia


subject: PUBCHEM.COMPOUND:5458171

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: PUBCHEM.COMPOUND:5458171

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:5458171

object_name: adult acute monocytic leukemia


subject: PUBCHEM.COMPOUND:5458171

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: PUBCHEM.COMPOUND:5458171

object_name: Adult Acute Monoblastic Leukemia


subject: PUBCHEM.COMPOUND:5458171

object_name: Adult Erythroleukemia


subject: PUBCHEM.COMPOUND:5458171

object_name: acute megakaryoblastic leukemia in adult


subject: CHEBI:50729

subject_name: Mitoxantrone

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:50729

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:50729

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:50729

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:50729

object_name: adult acute myeloid leukemia with del(5q)


subject: CHEBI:50729

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:50729

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: CHEBI:50729

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:50729

object_name: Adult Acute Myelomonocytic Leukemia


subject: CHEBI:50729

object_name: Adult Pure Erythroid Leukemia


subject: CHEBI:50729

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: CHEBI:50729

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: CHEBI:50729

object_name: adult acute monocytic leukemia


subject: CHEBI:50729

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: CHEBI:50729

object_name: Adult Acute Monoblastic Leukemia


subject: CHEBI:50729

object_name: Adult Erythroleukemia


subject: CHEBI:50729

object_name: acute megakaryoblastic leukemia in adult


subject: CHEBI:84363

object_name: Other specified hypotension


subject: CHEBI:84363

object_name: Syncope Related to COVID-19


subject: CHEBI:84363

object_name: Syncope, CTCAE 5.0


subject: CHEBI:84363

object_name: Syncope


subject: CHEBI:2376

subject_name: acarbose


subject: CHEBI:2376


subject: CHEBI:2376


subject: CHEBI:2376


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: cerebral palsy


subject: UMLS:C0376541

subject_name: Recombinant Erythropoietin


subject: PUBCHEM.COMPOUND:75163792

subject_name: Ibrexafungerp

object_name: vulvovaginal candidiasis


subject: PUBCHEM.COMPOUND:75163792

object_name: candidiasis


subject: PUBCHEM.COMPOUND:75163792

object_name: Candidiasis of vagina


subject: CHEBI:6456

subject_name: Lidocaine

object_name: post operative nausea and vomiting


subject: CHEBI:92076

subject_name: AFIMOXIFENE

object_name: Mammographically Dense Breast


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: delirium


subject: CHEBI:4466

object_name: Delirium, CTCAE


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: CHEBI:119915

subject_name: Fentanyl


subject: CHEBI:119915


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:6931


subject: CHEBI:4672

subject_name: Docetaxel

object_name: prostate adenocarcinoma


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: chronic kidney disease


subject: PUBCHEM.COMPOUND:5281767

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:7986

subject_name: Pentoxifylline


subject: CHEBI:27732

subject_name: Caffeine

object_name: Caffeine-related disorder


subject: CHEBI:82960

subject_name: Raltegravir

object_name: tuberculosis


subject: UMLS:C4077852

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:77335690

subject_name: Velpatasvir

object_name: hepatitis C


subject: CHEBI:136927

object_name: pancreatic neoplasm


subject: CHEBI:136927

object_name: exocrine pancreatic carcinoma


subject: CHEBI:136927

object_name: malignant pancreatic neoplasm


subject: CHEBI:58097

object_name: anesthesia; functional


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:9316

subject_name: Sufentanil


subject: UNII:Q46947FE7K

subject_name: Peginterferon alfa-2a

object_name: chronic hepatitis C virus infection


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: interstitial lung disease


subject: CHEBI:32016

object_name: connective tissue disorder


subject: PUBCHEM.COMPOUND:58298316

object_name: non-small cell lung carcinoma


subject: UMLS:C3897088

subject_name: Oral Azacitidine


subject: CHEBI:95341

subject_name: Baricitinib

object_name: rheumatoid arthritis


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: acute myeloid leukemia by FAB classification


subject: PUBCHEM.COMPOUND:596

object_name: acute myeloid leukemia


subject: UMLS:C0733521

subject_name: Ara-C


subject: UMLS:C0733521


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: CHEBI:42068

subject_name: Idarubicin


subject: CHEBI:42068


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: PUBCHEM.COMPOUND:131769963


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:90881

subject_name: Camptosar

object_name: lung cancer


subject: CHEBI:90881

object_name: lung neoplasm


subject: CHEBI:90881

object_name: lung carcinoma


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: Harmful pattern of substance use


subject: CHEBI:6887

object_name: substance abuse


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: mood disorder


subject: CHEBI:28939

object_name: Mood Alteration


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS


subject: UNII:71M78END5S


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:25681


subject: CHEBI:24848

subject_name: inositol


subject: CHEBI:24848


subject: CHEBI:70839

subject_name: Dasatinib

object_name: neoplasm


subject: CHEBI:190514


subject: CHEBI:49375


subject: MESH:D011819

subject_name: Rabies Vaccines

object_name: rabies


subject: CHEMBL.COMPOUND:CHEMBL2107909

subject_name: RABIES VACCINE


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: asthma


subject: UMLS:C3658854


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: type 1 diabetes mellitus 1


subject: UMLS:C0003442

object_name: type 1 diabetes mellitus


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UNII:3A58010674


subject: CHEBI:50692

subject_name: Mifepristone

object_name: Alzheimer disease


subject: CHEBI:9241

subject_name: Spironolactone

object_name: ADHF


subject: UNII:1FQ2RY5YHH

subject_name: Patiromer


subject: UMLS:C0678021

subject_name: Ad5CMV-p53 gene

object_name: Childhood Solid Neoplasm


subject: UMLS:C0678021

object_name: Adult Solid Neoplasm


subject: UMLS:C0678021

object_name: Solid Neoplasm


subject: UMLS:C0678021

object_name: adult lymphoma


subject: UMLS:C0678021

object_name: lymphoma


subject: UMLS:C0678021

object_name: pediatric lymphoma


subject: UMLS:C0677806

subject_name: adenovirus p53 gene therapy agent


subject: UMLS:C0677806


subject: UMLS:C0677806


subject: UMLS:C0677806


subject: UMLS:C0677806


subject: UMLS:C0677806


subject: CHEBI:78236

subject_name: N-acetyl-L-cysteinate

object_name: neuralgia


subject: CHEBI:78236

object_name: Neuropathic pain


subject: UNII:2SPH1IMO2V

subject_name: N-Acetyl-D-cysteine


subject: UNII:2SPH1IMO2V


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: CHEBI:28939


subject: CHEBI:28939

object_name: Cornelia de Lange syndrome


subject: CHEBI:75045

subject_name: Dabrafenib

object_name: Rare Childhood Malignant Neoplasm


subject: CHEBI:45783

subject_name: Imatinib


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:50731

subject_name: morphine sulfate pentahydrate

object_name: Tendon Injuries


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:74705

subject_name: Met-Leu


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:75722

subject_name: Tramadol


subject: UMLS:C0304229

subject_name: Experimental drug

object_name: Metastatic Microsatellite Stable Colorectal Carcinoma


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: tumor suppressor gene on chromosome 11


subject: UNII:52CMI0WC3Y

object_name: lung cancer


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: GTOPDB:11097

subject_name: efineptakin alfa

object_name: non-small cell lung carcinoma


subject: GTOPDB:11097


subject: GTOPDB:11097


subject: CHEMBL.COMPOUND:CHEMBL4594590

subject_name: EFINEPTAKIN ALFA


subject: CHEMBL.COMPOUND:CHEMBL4594590


subject: CHEMBL.COMPOUND:CHEMBL4594590


subject: UMLS:C3714111


subject: UMLS:C3714111


subject: UMLS:C3714111


subject: UNII:QT44II3WZP

subject_name: ULVIPRUBART

object_name: inclusion body myositis


subject: UMLS:C5783748

subject_name: Ulviprubart


subject: UMLS:C5783890

subject_name: Anti-KLRG1 Monoclonal Antibody ABC008


subject: CHEBI:6503

subject_name: LISINOPRIL

object_name: hypertension


subject: CHEBI:6503

object_name: Hypertension, CTCAE


subject: CHEBI:43755

subject_name: Lisinopril


subject: CHEBI:43755


subject: UMLS:C5960912

subject_name: Anti-PD-1/Anti-TIGIT Bispecific Antibody ZG005

object_name: neuroendocrine carcinoma


subject: UMLS:C5960912

object_name: small cell lung carcinoma


subject: UMLS:C5854622

subject_name: Anti-DLL3/DLL3/CD3 Trispecific Antibody ZG006


subject: UMLS:C5854622


subject: UMLS:C0111046

subject_name: Creon

object_name: pancreatitis


subject: UMLS:C0111046

object_name: Pancreatitis, CTCAE 5.0


subject: UMLS:C0111046

object_name: Pancreatitis, CTCAE 3.0


subject: UMLS:C0305062

subject_name: Tetanus Toxoid

object_name: haemophilus infectious disease


subject: UMLS:C0305062

object_name: diphtheria


subject: UMLS:C0305062

object_name: tetanus


subject: UMLS:C0305062

object_name: poliomyelitis


subject: UMLS:C0982332

subject_name: acellular pertussis vaccine, inactivated


subject: UMLS:C0982332


subject: UMLS:C0982332


subject: UMLS:C0982332


subject: MESH:C044237

subject_name: Haemophilus influenzae type b polysaccharide vaccine


subject: MESH:C044237

object_name: pertussis


subject: PR:000008945

subject_name: insulin-like growth factor 2 mRNA-binding protein 3


subject: CHEBI:5775

subject_name: Hydralazine

object_name: Childhood Breast Carcinoma


subject: CHEBI:5775

object_name: breast carcinoma


subject: CHEBI:5775

object_name: breast cancer


subject: UMLS:C1251704

subject_name: Lidocaine Patch

object_name: Mechanical complication due to intrauterine contraceptive device


subject: CHEBI:32599

object_name: atrial fibrillation


subject: CHEBI:32599

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:32599

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:71223

subject_name: Pralatrexate

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:71223

object_name: Disease Progression


subject: CHEBI:45783

subject_name: Imatinib

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:45783

object_name: Blast Phase


subject: DRUGBANK:DB19013

subject_name: Insulin efsitora alfa

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:13559282

subject_name: Ulipristal acetate

object_name: leiomyoma


subject: CHEBI:71025

subject_name: ulipristal


subject: CHEBI:28364

subject_name: Icosapent

object_name: Crohn disease


subject: CHEBI:28364

object_name: ulcerative colitis


subject: CHEBI:28364

object_name: inflammatory bowel disease 1


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: metastatic colorectal cancer


subject: CHEBI:68647

subject_name: Regorafenib


subject: GTOPDB:12989

subject_name: toripalimab


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: CHEBI:7936

subject_name: Paroxetine

object_name: Depressed mood


subject: CHEBI:7936

object_name: Cancer patients and suicide and depression


subject: CHEBI:7936

object_name: Depressed - symptom


subject: CHEBI:7936

object_name: Depression, CTCAE


subject: CHEBI:7936

object_name: Parkinson disease


subject: CHEBI:9943

subject_name: Venlafaxine


subject: CHEBI:9943


subject: CHEBI:9943


subject: CHEBI:9943


subject: CHEBI:9943


subject: CHEBI:38940

subject_name: Sunitinib

object_name: fibrosarcoma


subject: CHEBI:38940

object_name: adult fibrosarcoma


subject: CHEBI:38940

object_name: pediatric fibrosarcoma


subject: CHEBI:38940

object_name: undifferentiated pleomorphic sarcoma


subject: CHEBI:38940

object_name: adult liposarcoma


subject: CHEBI:38940

object_name: liposarcoma


subject: CHEBI:38940

object_name: pediatric liposarcoma


subject: CHEBI:38940

object_name: leiomyosarcoma


subject: CHEBI:38940

object_name: Childhood Leiomyosarcoma


subject: CHEBI:38940

object_name: Adult Leiomyosarcoma


subject: UMLS:C1176021


subject: UMLS:C1176021


subject: UMLS:C1176021


subject: UMLS:C1176021


subject: UMLS:C1176021


subject: UMLS:C1176021


subject: UMLS:C1176021


subject: UMLS:C1176021


subject: UMLS:C1176021


subject: UMLS:C1176021


subject: CHEBI:135515

subject_name: Bendamustine

object_name: adult lymphoma


subject: CHEBI:135515

object_name: lymphoma


subject: CHEBI:135515

object_name: pediatric lymphoma


subject: CHEBI:135515

object_name: T-Cell Lymphoma


subject: CHEBI:135515

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:135515

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:135515

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEBI:135515

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C3274621

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C3274621


subject: UMLS:C3274621


subject: UMLS:C3274621


subject: UMLS:C3274621


subject: UMLS:C3274621


subject: UMLS:C3274621


subject: UMLS:C3274621

object_name: non-Hodgkin lymphoma


subject: UMLS:C3274621


subject: UMLS:C3274621


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:31348

subject_name: Capecitabine

object_name: colon carcinoma


subject: CHEBI:31348

object_name: colon cancer


subject: CHEBI:45783


subject: CHEBI:45783

object_name: colorectal cancer


subject: CHEBI:45783


subject: CHEBI:45783

object_name: colorectal carcinoma


subject: CHEBI:45783

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:8764

subject_name: Mycophenolate mofetil

object_name: autoimmune hemolytic anemia


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415


subject: UNII:25E79B5CTM

subject_name: Denileukin diftitox

object_name: anaplastic large cell lymphoma


subject: UMLS:C0211023


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:40968

subject_name: Astaxanthin

object_name: osteoarthritis, knee


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab


subject: UNII:D99YVK4L0X

object_name: gastric adenocarcinoma


subject: UMLS:C1721684

subject_name: lexatumumab


subject: UMLS:C1721684


subject: CHEBI:95043

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:94807

subject_name: Nitazoxanide

object_name: hepatic encephalopathy


subject: CHEBI:231425

subject_name: tolvaptan

object_name: kidney disorder


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: Compulsion


subject: UNII:OX5LRQ5H6K

subject_name: FIANLIMAB

object_name: melanoma


subject: UMLS:C4329332

subject_name: Fianlimab


subject: CHEBI:8884

subject_name: Rocuronium

object_name: Neuromuscular inhibition


subject: CHEBI:8884

object_name: Neuromuscular block, function


subject: UNII:80YS8O1MBS

subject_name: CISATRACURIUM BESYLATE


subject: UNII:80YS8O1MBS


subject: CHEBI:140621

subject_name: Cisatracurium


subject: CHEBI:140621


subject: CHEBI:124959

subject_name: Tilarginine

object_name: hypertension


subject: CHEBI:124959

object_name: Hypertension, CTCAE


subject: UMLS:C0069477


subject: UMLS:C0069477


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C0013227


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: PUBCHEM.COMPOUND:132129813

subject_name: camlipixant

object_name: Cough


subject: PUBCHEM.COMPOUND:132129813

object_name: Cough, CTCAE


subject: UNII:TB7D2H7MZZ


subject: UNII:TB7D2H7MZZ


subject: DRUGBANK:DB19217

subject_name: Camlipixant


subject: DRUGBANK:DB19217


subject: CHEBI:31348

subject_name: Capecitabine

object_name: VIPoma


subject: CHEBI:31348

object_name: functional pancreatic neuroendocrine tumor


subject: CHEBI:31348

object_name: non-functional pancreatic neuroendocrine tumor


subject: CHEBI:31348

object_name: somatostatinoma


subject: CHEBI:31348

object_name: Metastatic well-differentiated neuroendocrine tumor


subject: CHEBI:31348

object_name: Adrenal Cortical Low Grade Carcinoma


subject: CHEBI:31348

object_name: Recurrent Merkel Cell Carcinoma


subject: CHEBI:31348

object_name: Recurrent Adrenal Cortical Carcinoma


subject: CHEBI:31348

object_name: malignant adrenal gland pheochromocytoma


subject: CHEBI:31348

object_name: Recurrent Adrenal Gland Pheochromocytoma


subject: CHEBI:31348

object_name: multiple endocrine neoplasia type 1


subject: CHEBI:31348

object_name: multiple endocrine neoplasia type 2B


subject: CHEBI:31348

object_name: multiple endocrine neoplasia type 2A


subject: CHEBI:31348

object_name: glucagonoma


subject: CHEBI:31348

object_name: Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8


subject: CHEBI:31348

object_name: Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7


subject: CHEBI:31348

object_name: Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7


subject: CHEBI:31348

object_name: Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7


subject: CHEBI:31348

object_name: Stage III Thyroid Gland Medullary Carcinoma AJCC v7


subject: CHEBI:31348

object_name: Somatostatinoma, malignant


subject: CHEBI:31348

object_name: Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8


subject: CHEBI:31348

object_name: Stage IV Cutaneous Merkel Cell Carcinoma AJCC v7


subject: CHEBI:31348

object_name: stage IV Merkel cell carcinoma


subject: CHEBI:31348

object_name: trabecular adenocarcinoma


subject: CHEBI:31348

object_name: cutaneous neuroendocrine carcinoma


subject: CHEBI:31348

object_name: thymic neuroendocrine tumor


subject: CHEBI:31348

object_name: Stage III Adrenal Cortex Carcinoma AJCC v8


subject: CHEBI:31348

object_name: Stage III Adrenal Cortex Carcinoma AJCC v7


subject: CHEBI:31348

object_name: Stage IV Adrenal Cortex Carcinoma AJCC v7


subject: CHEBI:31348

object_name: Stage IV Adrenal Cortex Carcinoma AJCC v8


subject: CHEBI:31348

object_name: Zollinger-Ellison syndrome


subject: CHEBI:31348

object_name: insulinoma


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: VIPoma


subject: UMLS:C0919079

object_name: neuroendocrine neoplasm


subject: UMLS:C0919079

object_name: functional pancreatic neuroendocrine tumor


subject: UMLS:C0919079

object_name: non-functional pancreatic neuroendocrine tumor


subject: UMLS:C0919079

object_name: somatostatinoma


subject: UMLS:C0919079

object_name: Metastatic well-differentiated neuroendocrine tumor


subject: UMLS:C0919079

object_name: Adrenal Cortical Low Grade Carcinoma


subject: UMLS:C0919079

object_name: Recurrent Merkel Cell Carcinoma


subject: UMLS:C0919079

object_name: Recurrent Adrenal Cortical Carcinoma


subject: UMLS:C0919079

object_name: malignant adrenal gland pheochromocytoma


subject: UMLS:C0919079

object_name: Recurrent Adrenal Gland Pheochromocytoma


subject: UMLS:C0919079

object_name: multiple endocrine neoplasia type 1


subject: UMLS:C0919079

object_name: multiple endocrine neoplasia type 2B


subject: UMLS:C0919079

object_name: multiple endocrine neoplasia type 2A


subject: UMLS:C0919079

object_name: glucagonoma


subject: UMLS:C0919079

object_name: Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8


subject: UMLS:C0919079

object_name: Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7


subject: UMLS:C0919079

object_name: Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7


subject: UMLS:C0919079

object_name: Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7


subject: UMLS:C0919079

object_name: Stage III Thyroid Gland Medullary Carcinoma AJCC v7


subject: UMLS:C0919079

object_name: Somatostatinoma, malignant


subject: UMLS:C0919079

object_name: Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8


subject: UMLS:C0919079

object_name: Stage IV Cutaneous Merkel Cell Carcinoma AJCC v7


subject: UMLS:C0919079

object_name: stage IV Merkel cell carcinoma


subject: UMLS:C0919079

object_name: trabecular adenocarcinoma


subject: UMLS:C0919079

object_name: cutaneous neuroendocrine carcinoma


subject: UMLS:C0919079

object_name: thymic neuroendocrine tumor


subject: UMLS:C0919079

object_name: Stage III Adrenal Cortex Carcinoma AJCC v8


subject: UMLS:C0919079

object_name: Stage III Adrenal Cortex Carcinoma AJCC v7


subject: UMLS:C0919079

object_name: Stage IV Adrenal Cortex Carcinoma AJCC v7


subject: UMLS:C0919079

object_name: Stage IV Adrenal Cortex Carcinoma AJCC v8


subject: UMLS:C0919079

object_name: Zollinger-Ellison syndrome


subject: UMLS:C0919079

object_name: insulinoma


subject: CHEBI:72564

subject_name: Temozolomide

object_name: VIPoma


subject: CHEBI:72564

object_name: functional pancreatic neuroendocrine tumor


subject: CHEBI:72564

object_name: non-functional pancreatic neuroendocrine tumor


subject: CHEBI:72564

object_name: somatostatinoma


subject: CHEBI:72564

object_name: Metastatic well-differentiated neuroendocrine tumor


subject: CHEBI:72564

object_name: Adrenal Cortical Low Grade Carcinoma


subject: CHEBI:72564

object_name: Recurrent Merkel Cell Carcinoma


subject: CHEBI:72564

object_name: Recurrent Adrenal Cortical Carcinoma


subject: CHEBI:72564

object_name: malignant adrenal gland pheochromocytoma


subject: CHEBI:72564

object_name: Recurrent Adrenal Gland Pheochromocytoma


subject: CHEBI:72564

object_name: multiple endocrine neoplasia type 1


subject: CHEBI:72564

object_name: multiple endocrine neoplasia type 2B


subject: CHEBI:72564

object_name: multiple endocrine neoplasia type 2A


subject: CHEBI:72564

object_name: glucagonoma


subject: CHEBI:72564

object_name: Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8


subject: CHEBI:72564

object_name: Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7


subject: CHEBI:72564

object_name: Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7


subject: CHEBI:72564

object_name: Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7


subject: CHEBI:72564

object_name: Stage III Thyroid Gland Medullary Carcinoma AJCC v7


subject: CHEBI:72564

object_name: Somatostatinoma, malignant


subject: CHEBI:72564

object_name: Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8


subject: CHEBI:72564

object_name: Stage IV Cutaneous Merkel Cell Carcinoma AJCC v7


subject: CHEBI:72564

object_name: stage IV Merkel cell carcinoma


subject: CHEBI:72564

object_name: trabecular adenocarcinoma


subject: CHEBI:72564

object_name: cutaneous neuroendocrine carcinoma


subject: CHEBI:72564

object_name: thymic neuroendocrine tumor


subject: CHEBI:72564

object_name: Stage III Adrenal Cortex Carcinoma AJCC v8


subject: CHEBI:72564

object_name: Stage III Adrenal Cortex Carcinoma AJCC v7


subject: CHEBI:72564

object_name: Stage IV Adrenal Cortex Carcinoma AJCC v7


subject: CHEBI:72564

object_name: Stage IV Adrenal Cortex Carcinoma AJCC v8


subject: CHEBI:72564

object_name: Zollinger-Ellison syndrome


subject: CHEBI:72564

object_name: insulinoma


subject: CHEBI:62880

subject_name: Veliparib

object_name: VIPoma


subject: CHEBI:62880

object_name: neuroendocrine neoplasm


subject: CHEBI:62880

object_name: functional pancreatic neuroendocrine tumor


subject: CHEBI:62880

object_name: non-functional pancreatic neuroendocrine tumor


subject: CHEBI:62880

object_name: somatostatinoma


subject: CHEBI:62880

object_name: Metastatic well-differentiated neuroendocrine tumor


subject: CHEBI:62880

object_name: Adrenal Cortical Low Grade Carcinoma


subject: CHEBI:62880

object_name: Recurrent Merkel Cell Carcinoma


subject: CHEBI:62880

object_name: Recurrent Adrenal Cortical Carcinoma


subject: CHEBI:62880

object_name: malignant adrenal gland pheochromocytoma


subject: CHEBI:62880

object_name: Recurrent Adrenal Gland Pheochromocytoma


subject: CHEBI:62880

object_name: multiple endocrine neoplasia type 1


subject: CHEBI:62880

object_name: multiple endocrine neoplasia type 2B


subject: CHEBI:62880

object_name: multiple endocrine neoplasia type 2A


subject: CHEBI:62880

object_name: glucagonoma


subject: CHEBI:62880

object_name: Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8


subject: CHEBI:62880

object_name: Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7


subject: CHEBI:62880

object_name: Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7


subject: CHEBI:62880

object_name: Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7


subject: CHEBI:62880

object_name: Stage III Thyroid Gland Medullary Carcinoma AJCC v7


subject: CHEBI:62880

object_name: Somatostatinoma, malignant


subject: CHEBI:62880

object_name: Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8


subject: CHEBI:62880

object_name: Stage IV Cutaneous Merkel Cell Carcinoma AJCC v7


subject: CHEBI:62880

object_name: stage IV Merkel cell carcinoma


subject: CHEBI:62880

object_name: trabecular adenocarcinoma


subject: CHEBI:62880

object_name: cutaneous neuroendocrine carcinoma


subject: CHEBI:62880

object_name: thymic neuroendocrine tumor


subject: CHEBI:62880

object_name: Stage III Adrenal Cortex Carcinoma AJCC v8


subject: CHEBI:62880

object_name: Stage III Adrenal Cortex Carcinoma AJCC v7


subject: CHEBI:62880

object_name: Stage IV Adrenal Cortex Carcinoma AJCC v7


subject: CHEBI:62880

object_name: Stage IV Adrenal Cortex Carcinoma AJCC v8


subject: CHEBI:62880

object_name: Zollinger-Ellison syndrome


subject: CHEBI:62880

object_name: insulinoma


subject: GTOPDB:8928

subject_name: pamrevlumab


subject: CHEMBL.COMPOUND:CHEMBL2109377

subject_name: PAMREVLUMAB


subject: UMLS:C2985186


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine

object_name: cancer


subject: PUBCHEM.COMPOUND:44424639

object_name: neoplasm


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:145371

subject_name: Binimetinib

object_name: low grade serous adenocarcinoma of ovary


subject: CHEBI:145371

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:145371

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:145371

object_name: exocrine pancreatic carcinoma


subject: CHEBI:145371

object_name: Malignant Solid Neoplasm


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:6121

subject_name: Ketamine

object_name: opiate dependence


subject: CHEBI:83766

subject_name: Olaparib

object_name: Ewing sarcoma


subject: CHEBI:8869

subject_name: Risedronic acid

object_name: postmenopausal osteoporosis


subject: CHEBI:8869

object_name: osteoporosis


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: coronary artery disorder


subject: CHEBI:39548

subject_name: Atorvastatin


subject: CHEBI:9150

subject_name: Simvastatin


subject: PR:000023323

subject_name: DNA mismatch repair protein MutH

object_name: Diarrhea rotavirus


subject: UNII:3XVL385Q0M

subject_name: Filgotinib

object_name: ankylosing spondylitis


subject: PUBCHEM.COMPOUND:23724990

subject_name: Phytate Sodium

object_name: calciphylaxis


subject: PUBCHEM.COMPOUND:23724990

object_name: Calcific Uraemic Arteriolopathy


subject: UMLS:C5198328


subject: UMLS:C5198328


subject: UMLS:C5417778

subject_name: Allogeneic Autophagosome-enriched Vaccine DPV-001

object_name: head and neck cancer


subject: UMLS:C4287754

subject_name: Ragifilimab


subject: UMLS:C4688466

subject_name: INCMGA 0012


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: strabismus


subject: CHEBI:73604

object_name: strabismus on exam (physical finding)


subject: CHEBI:50858

subject_name: corticosteroid

object_name: autoimmune pancreatitis


subject: CHEBI:50858

object_name: obstructive jaundice


subject: CHEBI:50858

object_name: IgG4-related sclerosing cholangitis


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: MESH:D000305


subject: MESH:D000305


subject: UMLS:C3540725

subject_name: Corticosteroid otologicals


subject: UMLS:C3540725


subject: UMLS:C3540725


subject: UMLS:C3539185

subject_name: Corticosteroid nasal preparations for topical use


subject: UMLS:C3539185


subject: UMLS:C3539185


subject: UMLS:C3540726

subject_name: Corticosteroid ophthalmologic and otologic preparations


subject: UMLS:C3540726


subject: UMLS:C3540726


subject: UMLS:C3540727

subject_name: Corticosteroids, topical for treatment of hemorrhoids and anal fissures


subject: UMLS:C3540727


subject: UMLS:C3540727


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: schizophrenia


subject: UMLS:C3534685

subject_name: Injection, aflibercept, 1 mg administered

object_name: metastatic colorectal cancer


subject: UMLS:C5203181

subject_name: Aflibercept Liquid Injection


subject: UNII:15C2VL427D

subject_name: Aflibercept


subject: UNII:8O74K609HN

subject_name: Obicetrapib

object_name: inherited lipid metabolism disorder


subject: UNII:8O74K609HN

object_name: Dyslipidemia


subject: CHEBI:15367

subject_name: Tretinoin

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:15367

object_name: acute myeloid leukemia


subject: CHEBI:50648

subject_name: Alitretinoin


subject: CHEBI:50648


subject: CHEBI:2948

subject_name: Azathioprine

object_name: encephalomyelitis


subject: CHEBI:2948

object_name: Inflammatory disease of the central nervous system


subject: PUBCHEM.COMPOUND:24984318

subject_name: Valbenazine

object_name: tardive dyskinesia


subject: PUBCHEM.COMPOUND:24984318

object_name: schizoaffective disorder


subject: PUBCHEM.COMPOUND:24984318

object_name: schizophrenia 18


subject: PUBCHEM.COMPOUND:24984318


subject: PUBCHEM.COMPOUND:24984318

object_name: endogenous depression


subject: PUBCHEM.COMPOUND:24984318

object_name: major depressive disorder


subject: PUBCHEM.COMPOUND:24984318

object_name: bipolar disorder


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: pain agnosia


subject: CHEBI:4466

object_name: Pain insensitivity


subject: CHEBI:4466

object_name: Acute Pain


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: CHEBI:73604

subject_name: Lys-Gly


subject: CHEBI:73604


subject: CHEBI:73604


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: head and neck squamous cell carcinoma


subject: CHEBI:80961


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:16349

subject_name: Citrulline

object_name: hypertension, pregnancy-induced


subject: CHEBI:16349

object_name: preeclampsia


subject: CHEBI:16349

object_name: preeclampsia and eclampsia


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: Diabetes


subject: CHEBI:94686

subject_name: Orlistat

object_name: Crigler-Najjar syndrome


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: rosacea


subject: CHEBI:91872

object_name: plasma cell myeloma


subject: CHEBI:28748

subject_name: Doxorubicin


subject: UMLS:C4524378

subject_name: Fluorine F 18 Integrin Alpha v Beta 6-targeted Peptide

object_name: colorectal carcinoma


subject: UMLS:C4524378

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4524378

object_name: breast carcinoma


subject: UMLS:C4524378

object_name: Secondary malignant neoplasm of breast


subject: UMLS:C4524378

object_name: Secondary malignant neoplasm of lung


subject: UMLS:C4524378

object_name: metastatic malignant neoplasm in the colon


subject: UMLS:C4524378

object_name: Secondary malignant neoplasm of rectum


subject: UMLS:C4524378

object_name: lung carcinoma


subject: UMLS:C5854521

subject_name: Anti-HER2/Topoisomerase I Inhibitor ADC TQB2102

object_name: Childhood Breast Carcinoma


subject: UMLS:C5854521


subject: UMLS:C5854521

object_name: breast cancer


subject: UMLS:C5854521

object_name: HER2 positive breast carcinoma


subject: UMLS:C5854521

object_name: Her2-receptor negative breast cancer


subject: CHEBI:46762

subject_name: geranylgeraniol

object_name: mevalonic aciduria


subject: CHEBI:46762

object_name: mevalonate kinase deficiency


subject: UNII:25DT549L0G


subject: UNII:R30772KCU0

subject_name: Isatuximab

object_name: smoldering plasma cell myeloma


subject: UMLS:C2983777


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex

object_name: brain neoplasm


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Recurrent Non-Muscle Invasive Bladder Carcinoma


subject: CHEBI:175901

object_name: Stage I Bladder Cancer AJCC v8


subject: CHEBI:175901

object_name: Stage 0a Bladder Cancer AJCC v8


subject: CHEBI:32139

object_name: urolithiasis


subject: CHEBI:32139

object_name: nephrolithiasis


subject: CHEBI:6504

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:6504

object_name: amyotrophic lateral sclerosis


subject: UMLS:C5959547

subject_name: JAK2V617F Inhibitor INCB160058

object_name: myeloproliferative neoplasm


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Metastatic castration-resistant prostate cancer


subject: CHEBI:31528

subject_name: Ebastine


subject: CHEBI:194186

subject_name: Tirzepatide

object_name: opiate dependence


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: plasma cell myeloma


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Hodgkin Disease


subject: UNII:4F4X42SYQ6

object_name: Lugano Classification Stage III Hodgkin Lymphoma AJCC v8


subject: UNII:4F4X42SYQ6

object_name: Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UNII:G6UF363ECX

object_name: prostate cancer


subject: UNII:G6UF363ECX

object_name: prostate neoplasm


subject: UMLS:C4308025

subject_name: AAA 617


subject: UMLS:C4308025


subject: CHEBI:140592

subject_name: Onalespib

object_name: Plexosarcoma


subject: CHEBI:140592

object_name: Childhood Gastrointestinal Stromal Tumor


subject: CHEBI:45783

subject_name: Imatinib


subject: CHEBI:45783


subject: UMLS:C5575040

object_name: cancer


subject: UMLS:C5575040

object_name: neoplasm


subject: DRUGBANK:DB16503


subject: CHEBI:231601

subject_name: trastuzumab

object_name: Malignant neoplasm of stomach stage IV


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: ADHF


subject: UMLS:C0021027

subject_name: Immunoglobulins

object_name: cytomegalovirus infection


subject: CHEBI:8107

subject_name: Phenytoin

object_name: Nodding Syndrome


subject: UMLS:C3714638

subject_name: Pyridoxine Drug Class


subject: CHEBI:27306

subject_name: vitamin B6


subject: CHEBI:66964

subject_name: Dronabinol

object_name: Muscle spasm


subject: CHEBI:66964

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:66964

object_name: amyotrophic lateral sclerosis


subject: CHEBI:134500

object_name: Oral Mucositis


subject: CHEBI:134500

object_name: stomatitis


subject: CHEBI:134500

object_name: oral mucositis


subject: CHEBI:94563

subject_name: Benzydamine


subject: CHEBI:94563


subject: CHEBI:94563


subject: GTOPDB:13396

subject_name: ivonescimab

object_name: squamous cell lung carcinoma


subject: UNII:Y0O332CU66

subject_name: IVONESCIMAB


subject: UMLS:C5669600

subject_name: Ivonescimab


subject: UNII:6XG22YQM2Z

subject_name: TIRAGOLUMAB


subject: UMLS:C4331912


subject: GTOPDB:9202

subject_name: setrusumab

object_name: osteogenesis imperfecta


subject: CHEMBL.COMPOUND:CHEMBL4297918

subject_name: SETRUSUMAB


subject: UMLS:C4726749


subject: UMLS:C0062527

subject_name: Engerix-B

object_name: inflammatory bowel disease


subject: UNII:01OUW6MA4L

subject_name: HYLAN G-F 20

object_name: osteoarthritis, knee


subject: CHEBI:17026

subject_name: Progesterone

object_name: Premature Labor


subject: CHEBI:93274

subject_name: Fluvoxamine

object_name: Depressed mood


subject: CHEBI:5118

subject_name: Fluoxetine


subject: CHEBI:30145

subject_name: lithium atom


subject: UNII:L2N7Z24B30

subject_name: lithium orotate


subject: CHEBI:49713

subject_name: Lithium cation


subject: UMLS:C3540800

subject_name: Lithium antipsychotics


subject: CHEBI:6950

subject_name: Mirtazapine


subject: UMLS:C1579361

subject_name: Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)


subject: CHEBI:3219

subject_name: Bupropion


subject: UNII:9603LN7R2Q

subject_name: Creatine Monohydrate

object_name: bipolar I disorder


subject: CHEBI:16919

subject_name: Creatine


subject: CHEBI:32660

subject_name: asparaginase

object_name: Infant T Acute Lymphoblastic Leukemia


subject: CHEBI:32660

object_name: Pre T-ALL


subject: CHEBI:32660

object_name: T-cell childhood acute lymphocytic leukemia


subject: CHEBI:32660

object_name: T-cell adult acute lymphocytic leukemia


subject: CHEBI:32660

object_name: precursor B-cell acute lymphoblastic leukemia


subject: CHEBI:32660

object_name: B-cell childhood acute lymphoblastic leukemia


subject: CHEBI:32660

object_name: B-cell adult acute lymphocytic leukemia


subject: CHEBI:32660

object_name: B-cell acute lymphoblastic leukemia


subject: CHEBI:32660

object_name: Childhood B Lymphoblastic Lymphoma


subject: CHEBI:32660

object_name: B Lymphoblastic Lymphoma


subject: CHEBI:32660

object_name: Adult B Lymphoblastic Lymphoma


subject: CHEBI:32660

object_name: T-cell childhood lymphoblastic lymphoma


subject: CHEBI:32660

object_name: Adult T Lymphoblastic Lymphoma


subject: CHEBI:32660

object_name: T-lymphoblastic lymphoma


subject: CHEBI:32660

object_name: Precursor T-lymphoblastic lymphoma/leukaemia recurrent


subject: CHEBI:32660

object_name: Precursor B-lymphoblastic lymphoma recurrent


subject: CHEBI:32660

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:32660

object_name: Precursor B-lymphoblastic lymphoma refractory


subject: CHEBI:32660

object_name: Refractory T Lymphoblastic Lymphoma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Infant T Acute Lymphoblastic Leukemia


subject: CHEBI:4026

object_name: Pre T-ALL


subject: CHEBI:4026

object_name: T-cell childhood acute lymphocytic leukemia


subject: CHEBI:4026

object_name: T-cell adult acute lymphocytic leukemia


subject: CHEBI:4026

object_name: precursor B-cell acute lymphoblastic leukemia


subject: CHEBI:4026

object_name: B-cell childhood acute lymphoblastic leukemia


subject: CHEBI:4026

object_name: B-cell adult acute lymphocytic leukemia


subject: CHEBI:4026

object_name: B-cell acute lymphoblastic leukemia


subject: CHEBI:4026

object_name: Childhood B Lymphoblastic Lymphoma


subject: CHEBI:4026

object_name: B Lymphoblastic Lymphoma


subject: CHEBI:4026

object_name: Adult B Lymphoblastic Lymphoma


subject: CHEBI:4026

object_name: T-cell childhood lymphoblastic lymphoma


subject: CHEBI:4026

object_name: Adult T Lymphoblastic Lymphoma


subject: CHEBI:4026

object_name: T-lymphoblastic lymphoma


subject: CHEBI:4026

object_name: Precursor T-lymphoblastic lymphoma/leukaemia recurrent


subject: CHEBI:4026

object_name: Precursor B-lymphoblastic lymphoma recurrent


subject: CHEBI:4026

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:4026

object_name: Precursor B-lymphoblastic lymphoma refractory


subject: CHEBI:4026

object_name: Refractory T Lymphoblastic Lymphoma


subject: CHEBI:4027

subject_name: Cyclophosphamide

object_name: Infant T Acute Lymphoblastic Leukemia


subject: CHEBI:4027

object_name: Pre T-ALL


subject: CHEBI:4027

object_name: T-cell childhood acute lymphocytic leukemia


subject: CHEBI:4027

object_name: T-cell adult acute lymphocytic leukemia


subject: CHEBI:4027

object_name: precursor B-cell acute lymphoblastic leukemia


subject: CHEBI:4027

object_name: B-cell childhood acute lymphoblastic leukemia


subject: CHEBI:4027

object_name: B-cell adult acute lymphocytic leukemia


subject: CHEBI:4027

object_name: B-cell acute lymphoblastic leukemia


subject: CHEBI:4027

object_name: Childhood B Lymphoblastic Lymphoma


subject: CHEBI:4027

object_name: B Lymphoblastic Lymphoma


subject: CHEBI:4027

object_name: Adult B Lymphoblastic Lymphoma


subject: CHEBI:4027

object_name: T-cell childhood lymphoblastic lymphoma


subject: CHEBI:4027

object_name: Adult T Lymphoblastic Lymphoma


subject: CHEBI:4027

object_name: T-lymphoblastic lymphoma


subject: CHEBI:4027

object_name: Precursor T-lymphoblastic lymphoma/leukaemia recurrent


subject: CHEBI:4027

object_name: Precursor B-lymphoblastic lymphoma recurrent


subject: CHEBI:4027

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:4027

object_name: Precursor B-lymphoblastic lymphoma refractory


subject: CHEBI:4027

object_name: Refractory T Lymphoblastic Lymphoma


subject: CHEBI:91872

object_name: Infant T Acute Lymphoblastic Leukemia


subject: CHEBI:91872

object_name: Pre T-ALL


subject: CHEBI:91872

object_name: T-cell childhood acute lymphocytic leukemia


subject: CHEBI:91872

object_name: T-cell adult acute lymphocytic leukemia


subject: CHEBI:91872

object_name: precursor B-cell acute lymphoblastic leukemia


subject: CHEBI:91872

object_name: B-cell childhood acute lymphoblastic leukemia


subject: CHEBI:91872

object_name: B-cell adult acute lymphocytic leukemia


subject: CHEBI:91872

object_name: B-cell acute lymphoblastic leukemia


subject: CHEBI:91872

object_name: Childhood B Lymphoblastic Lymphoma


subject: CHEBI:91872

object_name: B Lymphoblastic Lymphoma


subject: CHEBI:91872

object_name: Adult B Lymphoblastic Lymphoma


subject: CHEBI:91872

object_name: T-cell childhood lymphoblastic lymphoma


subject: CHEBI:91872

object_name: Adult T Lymphoblastic Lymphoma


subject: CHEBI:91872

object_name: T-lymphoblastic lymphoma


subject: CHEBI:91872

object_name: Precursor T-lymphoblastic lymphoma/leukaemia recurrent


subject: CHEBI:91872

object_name: Precursor B-lymphoblastic lymphoma recurrent


subject: CHEBI:91872

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:91872

object_name: Precursor B-lymphoblastic lymphoma refractory


subject: CHEBI:91872

object_name: Refractory T Lymphoblastic Lymphoma


subject: CHEBI:28748

subject_name: Doxorubicin

object_name: Infant T Acute Lymphoblastic Leukemia


subject: CHEBI:28748

object_name: Pre T-ALL


subject: CHEBI:28748

object_name: T-cell childhood acute lymphocytic leukemia


subject: CHEBI:28748

object_name: T-cell adult acute lymphocytic leukemia


subject: CHEBI:28748

object_name: precursor B-cell acute lymphoblastic leukemia


subject: CHEBI:28748

object_name: B-cell childhood acute lymphoblastic leukemia


subject: CHEBI:28748

object_name: B-cell adult acute lymphocytic leukemia


subject: CHEBI:28748

object_name: B-cell acute lymphoblastic leukemia


subject: CHEBI:28748

object_name: Childhood B Lymphoblastic Lymphoma


subject: CHEBI:28748

object_name: B Lymphoblastic Lymphoma


subject: CHEBI:28748

object_name: Adult B Lymphoblastic Lymphoma


subject: CHEBI:28748

object_name: T-cell childhood lymphoblastic lymphoma


subject: CHEBI:28748

object_name: Adult T Lymphoblastic Lymphoma


subject: CHEBI:28748

object_name: T-lymphoblastic lymphoma


subject: CHEBI:28748

object_name: Precursor T-lymphoblastic lymphoma/leukaemia recurrent


subject: CHEBI:28748

object_name: Precursor B-lymphoblastic lymphoma recurrent


subject: CHEBI:28748

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:28748

object_name: Precursor B-lymphoblastic lymphoma refractory


subject: CHEBI:28748

object_name: Refractory T Lymphoblastic Lymphoma


subject: CHEBI:4911

subject_name: Etoposide

object_name: Infant T Acute Lymphoblastic Leukemia


subject: CHEBI:4911

object_name: Pre T-ALL


subject: CHEBI:4911

object_name: T-cell childhood acute lymphocytic leukemia


subject: CHEBI:4911

object_name: T-cell adult acute lymphocytic leukemia


subject: CHEBI:4911

object_name: precursor B-cell acute lymphoblastic leukemia


subject: CHEBI:4911

object_name: B-cell childhood acute lymphoblastic leukemia


subject: CHEBI:4911

object_name: B-cell adult acute lymphocytic leukemia


subject: CHEBI:4911

object_name: B-cell acute lymphoblastic leukemia


subject: CHEBI:4911

object_name: Childhood B Lymphoblastic Lymphoma


subject: CHEBI:4911

object_name: B Lymphoblastic Lymphoma


subject: CHEBI:4911

object_name: Adult B Lymphoblastic Lymphoma


subject: CHEBI:4911

object_name: T-cell childhood lymphoblastic lymphoma


subject: CHEBI:4911

object_name: Adult T Lymphoblastic Lymphoma


subject: CHEBI:4911

object_name: T-lymphoblastic lymphoma


subject: CHEBI:4911

object_name: Precursor T-lymphoblastic lymphoma/leukaemia recurrent


subject: CHEBI:4911

object_name: Precursor B-lymphoblastic lymphoma recurrent


subject: CHEBI:4911

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:4911

object_name: Precursor B-lymphoblastic lymphoma refractory


subject: CHEBI:4911

object_name: Refractory T Lymphoblastic Lymphoma


subject: CHEBI:45783

subject_name: Imatinib

object_name: Infant T Acute Lymphoblastic Leukemia


subject: CHEBI:45783

object_name: Pre T-ALL


subject: CHEBI:45783

object_name: T-cell childhood acute lymphocytic leukemia


subject: CHEBI:45783

object_name: T-cell adult acute lymphocytic leukemia


subject: CHEBI:45783

object_name: precursor B-cell acute lymphoblastic leukemia


subject: CHEBI:45783

object_name: B-cell childhood acute lymphoblastic leukemia


subject: CHEBI:45783

object_name: B-cell adult acute lymphocytic leukemia


subject: CHEBI:45783

object_name: B-cell acute lymphoblastic leukemia


subject: CHEBI:45783

object_name: Childhood B Lymphoblastic Lymphoma


subject: CHEBI:45783

object_name: B Lymphoblastic Lymphoma


subject: CHEBI:45783

object_name: Adult B Lymphoblastic Lymphoma


subject: CHEBI:45783

object_name: T-cell childhood lymphoblastic lymphoma


subject: CHEBI:45783

object_name: Adult T Lymphoblastic Lymphoma


subject: CHEBI:45783

object_name: T-lymphoblastic lymphoma


subject: CHEBI:45783

object_name: Precursor T-lymphoblastic lymphoma/leukaemia recurrent


subject: CHEBI:45783

object_name: Precursor B-lymphoblastic lymphoma recurrent


subject: CHEBI:45783

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:45783

object_name: Precursor B-lymphoblastic lymphoma refractory


subject: CHEBI:45783

object_name: Refractory T Lymphoblastic Lymphoma


subject: CHEBI:8382

subject_name: Prednisone

object_name: Infant T Acute Lymphoblastic Leukemia


subject: CHEBI:8382

object_name: Pre T-ALL


subject: CHEBI:8382

object_name: T-cell childhood acute lymphocytic leukemia


subject: CHEBI:8382

object_name: T-cell adult acute lymphocytic leukemia


subject: CHEBI:8382

object_name: precursor B-cell acute lymphoblastic leukemia


subject: CHEBI:8382

object_name: B-cell childhood acute lymphoblastic leukemia


subject: CHEBI:8382

object_name: B-cell adult acute lymphocytic leukemia


subject: CHEBI:8382

object_name: B-cell acute lymphoblastic leukemia


subject: CHEBI:8382

object_name: Childhood B Lymphoblastic Lymphoma


subject: CHEBI:8382

object_name: B Lymphoblastic Lymphoma


subject: CHEBI:8382

object_name: Adult B Lymphoblastic Lymphoma


subject: CHEBI:8382

object_name: T-cell childhood lymphoblastic lymphoma


subject: CHEBI:8382

object_name: Adult T Lymphoblastic Lymphoma


subject: CHEBI:8382

object_name: T-lymphoblastic lymphoma


subject: CHEBI:8382

object_name: Precursor T-lymphoblastic lymphoma/leukaemia recurrent


subject: CHEBI:8382

object_name: Precursor B-lymphoblastic lymphoma recurrent


subject: CHEBI:8382

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:8382

object_name: Precursor B-lymphoblastic lymphoma refractory


subject: CHEBI:8382

object_name: Refractory T Lymphoblastic Lymphoma


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Infant T Acute Lymphoblastic Leukemia


subject: UNII:4F4X42SYQ6

object_name: Pre T-ALL


subject: UNII:4F4X42SYQ6

object_name: T-cell childhood acute lymphocytic leukemia


subject: UNII:4F4X42SYQ6

object_name: T-cell adult acute lymphocytic leukemia


subject: UNII:4F4X42SYQ6

object_name: precursor B-cell acute lymphoblastic leukemia


subject: UNII:4F4X42SYQ6

object_name: B-cell childhood acute lymphoblastic leukemia


subject: UNII:4F4X42SYQ6

object_name: B-cell adult acute lymphocytic leukemia


subject: UNII:4F4X42SYQ6

object_name: B-cell acute lymphoblastic leukemia


subject: UNII:4F4X42SYQ6

object_name: Childhood B Lymphoblastic Lymphoma


subject: UNII:4F4X42SYQ6

object_name: B Lymphoblastic Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Adult B Lymphoblastic Lymphoma


subject: UNII:4F4X42SYQ6

object_name: T-cell childhood lymphoblastic lymphoma


subject: UNII:4F4X42SYQ6

object_name: Adult T Lymphoblastic Lymphoma


subject: UNII:4F4X42SYQ6

object_name: T-lymphoblastic lymphoma


subject: UNII:4F4X42SYQ6

object_name: Precursor T-lymphoblastic lymphoma/leukaemia recurrent


subject: UNII:4F4X42SYQ6

object_name: Precursor B-lymphoblastic lymphoma recurrent


subject: UNII:4F4X42SYQ6

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: UNII:4F4X42SYQ6

object_name: Precursor B-lymphoblastic lymphoma refractory


subject: UNII:4F4X42SYQ6

object_name: Refractory T Lymphoblastic Lymphoma


subject: UMLS:C0295415

subject_name: rituximab

object_name: Infant T Acute Lymphoblastic Leukemia


subject: UMLS:C0295415

object_name: Pre T-ALL


subject: UMLS:C0295415

object_name: T-cell childhood acute lymphocytic leukemia


subject: UMLS:C0295415

object_name: T-cell adult acute lymphocytic leukemia


subject: UMLS:C0295415

object_name: precursor B-cell acute lymphoblastic leukemia


subject: UMLS:C0295415

object_name: B-cell childhood acute lymphoblastic leukemia


subject: UMLS:C0295415

object_name: B-cell adult acute lymphocytic leukemia


subject: UMLS:C0295415

object_name: B-cell acute lymphoblastic leukemia


subject: UMLS:C0295415

object_name: Childhood B Lymphoblastic Lymphoma


subject: UMLS:C0295415

object_name: B Lymphoblastic Lymphoma


subject: UMLS:C0295415

object_name: Adult B Lymphoblastic Lymphoma


subject: UMLS:C0295415

object_name: T-cell childhood lymphoblastic lymphoma


subject: UMLS:C0295415

object_name: Adult T Lymphoblastic Lymphoma


subject: UMLS:C0295415

object_name: T-lymphoblastic lymphoma


subject: UMLS:C0295415

object_name: Precursor T-lymphoblastic lymphoma/leukaemia recurrent


subject: UMLS:C0295415

object_name: Precursor B-lymphoblastic lymphoma recurrent


subject: UMLS:C0295415

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: UMLS:C0295415

object_name: Precursor B-lymphoblastic lymphoma refractory


subject: UMLS:C0295415

object_name: Refractory T Lymphoblastic Lymphoma


subject: UNII:T5IRO3534A

subject_name: Oncovin

object_name: Infant T Acute Lymphoblastic Leukemia


subject: UNII:T5IRO3534A

object_name: Pre T-ALL


subject: UNII:T5IRO3534A

object_name: T-cell childhood acute lymphocytic leukemia


subject: UNII:T5IRO3534A

object_name: T-cell adult acute lymphocytic leukemia


subject: UNII:T5IRO3534A

object_name: precursor B-cell acute lymphoblastic leukemia


subject: UNII:T5IRO3534A

object_name: B-cell childhood acute lymphoblastic leukemia


subject: UNII:T5IRO3534A

object_name: B-cell adult acute lymphocytic leukemia


subject: UNII:T5IRO3534A

object_name: B-cell acute lymphoblastic leukemia


subject: UNII:T5IRO3534A

object_name: Childhood B Lymphoblastic Lymphoma


subject: UNII:T5IRO3534A

object_name: B Lymphoblastic Lymphoma


subject: UNII:T5IRO3534A

object_name: Adult B Lymphoblastic Lymphoma


subject: UNII:T5IRO3534A

object_name: T-cell childhood lymphoblastic lymphoma


subject: UNII:T5IRO3534A

object_name: Adult T Lymphoblastic Lymphoma


subject: UNII:T5IRO3534A

object_name: T-lymphoblastic lymphoma


subject: UNII:T5IRO3534A

object_name: Precursor T-lymphoblastic lymphoma/leukaemia recurrent


subject: UNII:T5IRO3534A

object_name: Precursor B-lymphoblastic lymphoma recurrent


subject: UNII:T5IRO3534A

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: UNII:T5IRO3534A

object_name: Precursor B-lymphoblastic lymphoma refractory


subject: UNII:T5IRO3534A

object_name: Refractory T Lymphoblastic Lymphoma


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine

object_name: Infant T Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:3717450

object_name: Pre T-ALL


subject: PUBCHEM.COMPOUND:3717450

object_name: T-cell childhood acute lymphocytic leukemia


subject: PUBCHEM.COMPOUND:3717450

object_name: T-cell adult acute lymphocytic leukemia


subject: PUBCHEM.COMPOUND:3717450

object_name: precursor B-cell acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:3717450

object_name: B-cell childhood acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:3717450

object_name: B-cell adult acute lymphocytic leukemia


subject: PUBCHEM.COMPOUND:3717450

object_name: B-cell acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:3717450

object_name: Childhood B Lymphoblastic Lymphoma


subject: PUBCHEM.COMPOUND:3717450

object_name: B Lymphoblastic Lymphoma


subject: PUBCHEM.COMPOUND:3717450

object_name: Adult B Lymphoblastic Lymphoma


subject: PUBCHEM.COMPOUND:3717450

object_name: T-cell childhood lymphoblastic lymphoma


subject: PUBCHEM.COMPOUND:3717450

object_name: Adult T Lymphoblastic Lymphoma


subject: PUBCHEM.COMPOUND:3717450

object_name: T-lymphoblastic lymphoma


subject: PUBCHEM.COMPOUND:3717450

object_name: Precursor T-lymphoblastic lymphoma/leukaemia recurrent


subject: PUBCHEM.COMPOUND:3717450

object_name: Precursor B-lymphoblastic lymphoma recurrent


subject: PUBCHEM.COMPOUND:3717450

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:3717450

object_name: Precursor B-lymphoblastic lymphoma refractory


subject: PUBCHEM.COMPOUND:3717450

object_name: Refractory T Lymphoblastic Lymphoma


subject: CHEBI:28445

subject_name: vincristine

object_name: Infant T Acute Lymphoblastic Leukemia


subject: CHEBI:28445

object_name: Pre T-ALL


subject: CHEBI:28445

object_name: T-cell childhood acute lymphocytic leukemia


subject: CHEBI:28445

object_name: T-cell adult acute lymphocytic leukemia


subject: CHEBI:28445

object_name: precursor B-cell acute lymphoblastic leukemia


subject: CHEBI:28445

object_name: B-cell childhood acute lymphoblastic leukemia


subject: CHEBI:28445

object_name: B-cell adult acute lymphocytic leukemia


subject: CHEBI:28445

object_name: B-cell acute lymphoblastic leukemia


subject: CHEBI:28445

object_name: Childhood B Lymphoblastic Lymphoma


subject: CHEBI:28445

object_name: B Lymphoblastic Lymphoma


subject: CHEBI:28445

object_name: Adult B Lymphoblastic Lymphoma


subject: CHEBI:28445

object_name: T-cell childhood lymphoblastic lymphoma


subject: CHEBI:28445

object_name: Adult T Lymphoblastic Lymphoma


subject: CHEBI:28445

object_name: T-lymphoblastic lymphoma


subject: CHEBI:28445

object_name: Precursor T-lymphoblastic lymphoma/leukaemia recurrent


subject: CHEBI:28445

object_name: Precursor B-lymphoblastic lymphoma recurrent


subject: CHEBI:28445

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:28445

object_name: Precursor B-lymphoblastic lymphoma refractory


subject: CHEBI:28445

object_name: Refractory T Lymphoblastic Lymphoma


subject: CHEBI:2453

subject_name: Acyclovir

object_name: herpes simplex


subject: CHEBI:188454

object_name: lymphoma


subject: CHEBI:188454

object_name: neoplasm


subject: UMLS:C1533733


subject: UMLS:C1533733


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F

object_name: Adenocarcinoma gastric stage IV with metastases


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: CHEBI:125400

subject_name: actinomycin D

object_name: gestational trophoblastic neoplasm


subject: CHEBI:27666

subject_name: Dactinomycin


subject: CHEBI:8673

subject_name: Pyrimethamine

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: persistent idiopathic facial pain


subject: UMLS:C4547969

subject_name: apatinib mesylate

object_name: Stomach cancer


subject: UMLS:C4547969

object_name: gastric cancer


subject: UMLS:C4547969


subject: CHEBI:136044

subject_name: Fimasartan

object_name: hypertension


subject: CHEBI:136044

object_name: Hypertension, CTCAE


subject: CHEBI:136044

object_name: type 2 diabetes mellitus


subject: CHEBI:136044

object_name: Diabetes


subject: CHEBI:136044

object_name: diabetes mellitus


subject: PUBCHEM.COMPOUND:57389748

subject_name: Linagliptin


subject: PUBCHEM.COMPOUND:57389748


subject: PUBCHEM.COMPOUND:57389748


subject: PUBCHEM.COMPOUND:57389748


subject: PUBCHEM.COMPOUND:57389748


subject: MESH:D000086663

subject_name: COVID-19 Vaccines

object_name: influenza


subject: UMLS:C5400806

subject_name: COVID-19 VACCINE


subject: PUBCHEM.COMPOUND:6435378

subject_name: iloprost

object_name: pulmonary hypertension


subject: PUBCHEM.COMPOUND:6435378

object_name: Pulmonary Hypertension, CTCAE


subject: PUBCHEM.COMPOUND:6435378

object_name: persistent fetal circulation syndrome


subject: PUBCHEM.COMPOUND:6435378

object_name: acute respiratory distress syndrome


subject: PUBCHEM.COMPOUND:6435378

object_name: congenital heart disease


subject: UMLS:C1178580

subject_name: fenugreek seed preparation

object_name: abdominal obesity-metabolic syndrome


subject: UMLS:C1178580

object_name: metabolic syndrome X


subject: CHEBI:9168

subject_name: Sirolimus

object_name: kaposiform hemangioendothelioma


subject: CHEBI:9168

object_name: hemangioma


subject: UNII:8M7YSN2KII

subject_name: nortramadol


subject: UNII:8M7YSN2KII


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UniProtKB:P15379-4


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Vaginal Atrophy


subject: UMLS:C0592155

subject_name: Syntocinon


subject: PUBCHEM.COMPOUND:22023730

subject_name: Ganaxolone

object_name: Refractory status epilepticus


subject: MESH:C000730654

subject_name: nanocurcumin

object_name: ankylosing spondylitis


subject: CHEBI:135983

subject_name: Teriparatide

object_name: Stress Fracture


subject: HMDB:HMDB0253501

subject_name: Insulin degludec

object_name: type 2 diabetes mellitus


subject: HMDB:HMDB0253501

object_name: Diabetes


subject: HMDB:HMDB0253501

object_name: diabetes mellitus


subject: UMLS:C2080467

subject_name: Phenobarbital Sodium Liquid Injection

object_name: Neonatal seizure


subject: CHEBI:8069

subject_name: Phenobarbital


subject: CHEBI:71940

subject_name: Tadalafil

object_name: impotence


subject: CHEBI:71940

object_name: Unable to perform sex


subject: CHEBI:10119

subject_name: Ziprasidone

object_name: bipolar disorder


subject: CHEBI:10119

object_name: Mania, CTCAE


subject: CHEBI:10119

object_name: Mania


subject: CHEBI:10119

object_name: major affective disorder 1


subject: RXCUI:284756

subject_name: Kaletra

object_name: HIV infection


subject: UMLS:C2985183

object_name: prostate carcinoma


subject: UMLS:C2985183

object_name: prostate cancer


subject: UNII:4T36H88UA7

subject_name: Apalutamide


subject: UNII:4T36H88UA7


subject: CHEBI:134716

subject_name: Brexpiprazole

object_name: endogenous depression


subject: CHEBI:134716

object_name: major depressive disorder


subject: CHEBI:6030

subject_name: Isoniazid

object_name: asthma


subject: CHEBI:114785

subject_name: Erlotinib

object_name: non-small cell squamous lung carcinoma


subject: CHEBI:52717

subject_name: Bortezomib

object_name: kidney failure


subject: CHEBI:52717

object_name: Renal Failure, CTCAE


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab


subject: UNII:4Z63YK6E0E


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:63791


subject: CHEBI:74947

subject_name: Thalidomide


subject: CHEBI:74947


subject: UMLS:C0879266

subject_name: Autologous Tumor Cell Vaccine

object_name: adult lymphoma


subject: UMLS:C0879266

object_name: lymphoma


subject: UMLS:C0879266

object_name: pediatric lymphoma


subject: PUBCHEM.COMPOUND:168009928

subject_name: Keyhole limpet hemocyanin


subject: PUBCHEM.COMPOUND:168009928


subject: PUBCHEM.COMPOUND:168009928


subject: UNII:FV4Y0JO2CX

subject_name: keyhole-limpet hemocyanin


subject: UNII:FV4Y0JO2CX


subject: UNII:FV4Y0JO2CX


subject: CHEMBL.COMPOUND:CHEMBL5314988

subject_name: KEYHOLE LIMPET HEMOCYANIN


subject: CHEMBL.COMPOUND:CHEMBL5314988


subject: CHEMBL.COMPOUND:CHEMBL5314988


subject: UMLS:C0064332


subject: UMLS:C0064332


subject: UMLS:C0064332


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: UNII:8WL68J66B9

subject_name: HEPALATIDE

object_name: hepatitis D


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Postoperative Hemorrhage


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: Solid Neoplasm


subject: UMLS:C2034472

subject_name: parenteral antibacterial agents

object_name: bacterial infectious disease


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Advanced Melanoma


subject: UMLS:C5444737

subject_name: Flaxseed antigen

object_name: Childhood Breast Carcinoma


subject: UMLS:C5444737

object_name: breast carcinoma


subject: UMLS:C5444737

object_name: breast cancer


subject: UMLS:C5444737

object_name: Hot Flashes, CTCAE


subject: UMLS:C5444737

object_name: Hot flashes


subject: UMLS:C5444737

object_name: Menopausal Symptom


subject: UMLS:C5444737

object_name: unspecified adult solid tumor, protocol specific


subject: DRUGBANK:DB10708

subject_name: Flax seed


subject: DRUGBANK:DB10708


subject: DRUGBANK:DB10708


subject: DRUGBANK:DB10708


subject: DRUGBANK:DB10708


subject: DRUGBANK:DB10708


subject: DRUGBANK:DB10708


subject: UMLS:C5785442

object_name: non-small cell lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5315075

subject_name: SUSOCTOCOG ALFA

object_name: acquired hemophilia A


subject: CHEMBL.COMPOUND:CHEMBL2108455

subject_name: octocog alfa


subject: UMLS:C0718247

subject_name: Active brand of pseudoephedrine-triprolidine

object_name: influenza


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:28887

subject_name: Ofatumumab


subject: UMLS:C1541395


subject: CHEBI:107736

subject_name: Metoclopramide

object_name: Gastroparesis due to diabetes mellitus


subject: CHEBI:107736

object_name: gastroparesis


subject: CHEBI:107736

object_name: Gastroparesis, CTCAE


subject: CHEBI:107736

object_name: type 2 diabetes mellitus


subject: CHEBI:107736

object_name: Diabetes


subject: CHEBI:107736

object_name: diabetes mellitus


subject: CHEBI:107736

object_name: Delayed gastric emptying


subject: CHEBI:499361

subject_name: Aprepitant

object_name: Nausea and vomiting


subject: CHEBI:499361

object_name: lymphoproliferative syndrome


subject: CHEBI:499361

object_name: myeloproliferative neoplasm


subject: CHEBI:499361

object_name: Myelodysplasia


subject: CHEBI:499361

object_name: Childhood Solid Neoplasm


subject: CHEBI:499361

object_name: Adult Solid Neoplasm


subject: CHEBI:499361

object_name: Solid Neoplasm


subject: CHEBI:499361

object_name: leukemia


subject: CHEBI:499361

object_name: childhood leukemia


subject: CHEBI:499361

object_name: adult lymphoma


subject: CHEBI:499361

object_name: lymphoma


subject: CHEBI:499361

object_name: pediatric lymphoma


subject: CHEBI:7774

subject_name: Zofran


subject: CHEBI:7774


subject: CHEBI:7774


subject: CHEBI:7774


subject: CHEBI:7774


subject: CHEBI:7774


subject: CHEBI:7774


subject: CHEBI:7774


subject: CHEBI:7774


subject: CHEBI:7774


subject: CHEBI:7774


subject: CHEBI:7774


subject: CHEBI:7773

subject_name: Ondansetron


subject: CHEBI:7773


subject: CHEBI:7773


subject: CHEBI:7773


subject: CHEBI:7773


subject: CHEBI:7773


subject: CHEBI:7773


subject: CHEBI:7773


subject: CHEBI:7773


subject: CHEBI:7773


subject: CHEBI:7773


subject: CHEBI:7773


subject: MESH:C000627770

subject_name: folfirinox

object_name: colorectal cancer


subject: MESH:C000627770

object_name: colorectal carcinoma


subject: MESH:C000627770

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: rectal carcinoma


subject: PUBCHEM.COMPOUND:43805

object_name: rectal cancer


subject: PUBCHEM.COMPOUND:43805

object_name: Childhood Rectal Carcinoma


subject: PUBCHEM.COMPOUND:43805

object_name: Effects of chemotherapy


subject: PUBCHEM.COMPOUND:43805

object_name: rectal neoplasm


subject: PUBCHEM.COMPOUND:43805

object_name: Neoplasm of cecum and/or colon and/or rectum


subject: PUBCHEM.COMPOUND:43805

object_name: intestinal cancer


subject: PUBCHEM.COMPOUND:43805

object_name: intestinal neoplasm


subject: PUBCHEM.COMPOUND:43805

object_name: intestinal disorder


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:80961


subject: CHEBI:80961


subject: CHEBI:80961


subject: CHEBI:80961


subject: CHEBI:80961


subject: CHEBI:80961


subject: CHEBI:80961

object_name: colorectal neoplasm


subject: CHEBI:80961


subject: CHEBI:80961


subject: CHEBI:80961


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: UNII:KXG2PJ551I

subject_name: Avelumab


subject: UNII:KXG2PJ551I


subject: UNII:KXG2PJ551I


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: CHEBI:4445

subject_name: Desflurane

object_name: complete trisomy 21


subject: CHEBI:4445

object_name: Down syndrome


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130


subject: CHEBI:49575

subject_name: Diazepam

object_name: epilepsy


subject: CHEBI:142432

subject_name: Vericiguat

object_name: coronary artery disorder


subject: CHEBI:142432

object_name: coronary atherosclerosis


subject: CHEBI:4856

subject_name: Esmolol

object_name: septic shock


subject: UMLS:C3641122

object_name: breast neoplasm


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Oral Mucositis


subject: CHEBI:22652

object_name: stomatitis


subject: CHEBI:22652

object_name: oral mucositis


subject: UNII:FM5526K07A

subject_name: ZINC ACETATE


subject: UNII:FM5526K07A


subject: UNII:FM5526K07A


subject: CHEBI:15346

subject_name: Coenzyme A

object_name: hyperlipoproteinemia


subject: UMLS:C4722532

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C4727210

subject_name: Cadonilimab

object_name: liver carcinoma


subject: UMLS:C5669600

subject_name: Ivonescimab


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: uterine corpus choriocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: choriocarcinoma of testis


subject: UNII:2S9ZZM9Q9V

object_name: choriocarcinoma


subject: UMLS:C2346810


subject: UMLS:C2346810


subject: UMLS:C2346810


subject: CHEBI:64073

object_name: diabetes mellitus


subject: UNII:9P1872D4OL

subject_name: Exenatide


subject: CHEBI:6801

subject_name: Metformin

object_name: head and neck squamous cell carcinoma


subject: UNII:NDM64RSJ42

subject_name: PASRITAMIG

object_name: castration-resistant prostate carcinoma


subject: CHEBI:5312

subject_name: gentamicin sulfate

object_name: epidermolysis bullosa


subject: UNII:8X7386QRLV

subject_name: GENTAMICIN SULFATE


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin


subject: CHEBI:33325

subject_name: radium atom

object_name: prostate carcinoma


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Avitaminosis


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: vitamin D deficiency


subject: UNII:1C6V77QF41


subject: CHEBI:16822

subject_name: choline sulfate

object_name: Cannabis use


subject: CHEBI:15354

subject_name: Choline


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: ischemia


subject: DRUGBANK:DB18171

object_name: plasma cell myeloma


subject: UNII:LA88IH4O02

subject_name: Mezigdomide


subject: CHEBI:72690

subject_name: Pomalidomide


subject: UMLS:C4045564

subject_name: Imnovid


subject: CHEBI:145499

subject_name: Donepezil

object_name: osteoporosis


subject: CHEBI:145499

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:145499

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:145499

object_name: Osteoporosis, CTCAE 3.0


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: Childhood Solid Neoplasm


subject: UNII:5S371K6132

object_name: Adult Solid Neoplasm


subject: UNII:5S371K6132

object_name: Solid Neoplasm


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: UMLS:C0599934

subject_name: Vaccines, Peptide

object_name: melanoma


subject: UMLS:C0599934

object_name: mucosal melanoma


subject: UMLS:C0599934

object_name: metastatic melanoma


subject: UMLS:C3896650

subject_name: Long Peptide Vaccine 7


subject: UMLS:C3896650


subject: UMLS:C3896650


subject: CHEBI:90936

subject_name: Alectinib

object_name: non-small cell lung carcinoma


subject: CHEBI:90936

object_name: ALK gene mutation


subject: CHEBI:90936

object_name: MET Gene Mutation


subject: CHEBI:90936

object_name: ROS1 Gene Mutation


subject: CHEBI:90936

object_name: EGFR gene mutation


subject: CHEBI:64310

subject_name: Crizotinib


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:90943

subject_name: Osimertinib


subject: CHEBI:90943


subject: CHEBI:90943


subject: CHEBI:90943


subject: CHEBI:231369

subject_name: Savolitinib


subject: CHEBI:231369


subject: CHEBI:231369


subject: CHEBI:231369


subject: CHEBI:231369


subject: CHEBI:75929

object_name: spinal cord injury


subject: CHEBI:40009

subject_name: Cycloserine


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: periarthritis


subject: CHEBI:75929

object_name: Compulsion


subject: CHEBI:40009


subject: CHEBI:17026

subject_name: Progesterone

object_name: Premature birth


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: Crohn disease


subject: CHEBI:91899

object_name: primary biliary cholangitis


subject: CHEBI:3207

subject_name: Budesonide


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Carcinoma breast stage IV


subject: UMLS:C5854401

subject_name: Anti-c-Met/MMAE ADC MYTX-011


subject: UMLS:C5854401

object_name: Advanced Lung Non-Squamous Non-Small Cell Carcinoma


subject: UMLS:C5854401

object_name: Advanced Lung Non-Small Cell Squamous Carcinoma


subject: UMLS:C5854401

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C5854401

object_name: Non-small cell lung cancer stage IIIB


subject: CHEBI:30879

subject_name: alcohol

object_name: Benign thyroid nodule


subject: CHEBI:30879

object_name: Thyroid cyst


subject: CHEBI:30879

object_name: Mass of thyroid gland


subject: CHEBI:16236

subject_name: Ethanol


subject: CHEBI:16236


subject: CHEBI:16236


subject: CHEBI:78770

subject_name: ethylene glycol monododecyl ether


subject: CHEBI:78770


subject: CHEBI:78770


subject: PUBCHEM.COMPOUND:2724258

subject_name: Polyethylene glycol monododecyl ether


subject: PUBCHEM.COMPOUND:2724258


subject: PUBCHEM.COMPOUND:2724258


subject: PUBCHEM.COMPOUND:76459

subject_name: Heptaethylene glycol monododecyl ether


subject: PUBCHEM.COMPOUND:76459


subject: PUBCHEM.COMPOUND:76459


subject: CHEBI:46859

subject_name: Polidocanol


subject: CHEBI:46859


subject: CHEBI:46859


subject: CHEBI:31355

subject_name: Carboplatin

object_name: ovarian cancer


subject: CHEBI:31355

object_name: peritoneum cancer


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:6887

object_name: Fatigue


subject: CHEBI:6887

object_name: sarcoidosis


subject: CHEBI:6887

object_name: sarcoidosis, susceptibility to, 1


subject: CHEBI:30496

subject_name: Sulfur hexafluoride

object_name: Premature infant


subject: CHEBI:30496

object_name: Premature birth


subject: CHEBI:232799

subject_name: insulin lispro

object_name: type 2 diabetes mellitus


subject: CHEBI:188074

object_name: aneurysm


subject: CHEBI:188074


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: CHEBI:50122


subject: UNII:AF75XOF6W3

subject_name: Relatlimab

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:AF75XOF6W3

object_name: Refractory Malignant Solid Neoplasm


subject: UNII:AF75XOF6W3

object_name: Plasma cell myeloma refractory


subject: UNII:AF75XOF6W3

object_name: Advanced Lymphoma


subject: UNII:AF75XOF6W3

object_name: Refractory Lymphoma


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: insomnia


subject: CHEBI:4466

object_name: Insomnia, CTCAE 3.0


subject: CHEBI:4466

object_name: Insomnia, CTCAE 5.0


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: CHEBI:5938

subject_name: Interferon beta-1b

object_name: multiple sclerosis


subject: CHEBI:116735

subject_name: Benzocaine

object_name: Pain Relief


subject: CHEBI:116735

object_name: pain agnosia


subject: CHEBI:116735

object_name: Pain insensitivity


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: liver carcinoma


subject: CHEBI:114785

subject_name: Erlotinib


subject: CHEBI:6121

subject_name: Ketamine

object_name: Depressed mood


subject: CHEBI:6121

object_name: Cancer patients and suicide and depression


subject: CHEBI:6121

object_name: Depressed - symptom


subject: CHEBI:6121

object_name: Depression, CTCAE


subject: CHEBI:116735

object_name: infectious otitis media


subject: CHEBI:116735

object_name: Acute otitis media


subject: CHEBI:8802

subject_name: Remifentanil

object_name: hypotension


subject: CHEBI:8802

object_name: Hypotension, CTCAE


subject: CHEBI:8802

object_name: Bradycardia by ECG Finding


subject: CHEBI:8802

object_name: Bradycardia


subject: CHEBI:16199

subject_name: Urea

object_name: atopic eczema


subject: CHEBI:28358

subject_name: rac-lactic acid


subject: CHEBI:42111

subject_name: D-Lactic acid


subject: CHEBI:16411

subject_name: Indoleacetic acid


subject: CHEBI:78320

subject_name: Lactic acid


subject: CHEBI:50692

subject_name: Mifepristone

object_name: Abortion Failure


subject: CHEBI:63610

subject_name: Misoprostol


subject: CHEBI:71219

subject_name: Pazopanib

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:71219

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:38940

subject_name: Sunitinib


subject: CHEBI:38940


subject: DRUGBANK:DB14362

subject_name: Moringa oleifera leaf

object_name: dental pulp necrosis


subject: CHEBI:83766

subject_name: Olaparib

object_name: lung cancer


subject: CHEBI:83766

object_name: lung neoplasm


subject: CHEBI:83766

object_name: lung carcinoma


subject: MESH:D002136

subject_name: Calcium, Dietary

object_name: secondary hyperparathyroidism


subject: UMLS:C3540037

subject_name: CALCIUM SUPPLEMENTS


subject: UNII:WY779SQ0XW

subject_name: CALCIUM


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:22984

subject_name: Calcium


subject: UMLS:C2936886

subject_name: Calcium [EPC]


subject: UMLS:C3714611

subject_name: Calcium Drug Class


subject: CHEBI:93775

subject_name: Amethopterin

object_name: ectopic pregnancy


subject: CHEBI:93775

object_name: infertility


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: head and neck squamous cell carcinoma


subject: UMLS:C0879636

subject_name: IMC C225


subject: PUBCHEM.COMPOUND:135565596

subject_name: Copanlisib


subject: CHEBI:173077


subject: CHEBI:38940

object_name: cancer


subject: UMLS:C3819106

subject_name: Pedia-Lax Probiotic

object_name: Helicobacter pylori infection


subject: UNII:EC1O2FB9FV

subject_name: SATOREOTIDE TETRAXETAN

object_name: neuroendocrine neoplasm


subject: DRUGBANK:DB16323

subject_name: Satoreotide tetraxetan


subject: CHEBI:41423

subject_name: Celecoxib

object_name: Compulsion


subject: GTOPDB:13792

subject_name: iparomlimab

object_name: colon carcinoma


subject: GTOPDB:13792

object_name: colorectal cancer


subject: GTOPDB:13792

object_name: colon cancer


subject: UNII:FN3VWV28BC

subject_name: IPAROMLIMAB


subject: UNII:FN3VWV28BC


subject: UNII:FN3VWV28BC


subject: UMLS:C5669553

subject_name: Iparomlimab


subject: UMLS:C5669553


subject: UMLS:C5669553


subject: UMLS:C5226998

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:73629

subject_name: Phe-Asp-Cys

object_name: type 2 diabetes mellitus


subject: CHEBI:38848

subject_name: perflunafene


subject: PR:000001881

subject_name: lymphocyte activation gene 3 protein


subject: PUBCHEM.COMPOUND:72680331

subject_name: Gemigliptin


subject: UMLS:C4760860

object_name: B-cell chronic lymphocytic leukemia


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Unresectable NUT Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Metastatic NUT Carcinoma


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: PUBCHEM.COMPOUND:16760419

subject_name: Etoposide phosphate


subject: PUBCHEM.COMPOUND:16760419


subject: CHEBI:95082

subject_name: Molibresib


subject: CHEBI:95082


subject: PUBCHEM.COMPOUND:52934829


subject: PUBCHEM.COMPOUND:52934829


subject: UNII:K04D7I4BCH

subject_name: MOLIBRESIB BESYLATE


subject: UNII:K04D7I4BCH


subject: UMLS:C5204817

subject_name: molibresib besylate


subject: UMLS:C5204817


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:15365

object_name: colorectal carcinoma


subject: CHEBI:15365

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:6916

subject_name: Mexiletine

object_name: Becker disease


subject: CHEBI:6916

object_name: Thomsen disease


subject: CHEBI:6916

object_name: Thomsen and Becker disease


subject: CHEBI:6916

object_name: paramyotonia congenita of Von Eulenburg


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: non-small cell squamous lung carcinoma


subject: CHEBI:3509

object_name: pneumonia


subject: CHEBI:3509

object_name: COVID-19-Associated Pneumonia


subject: PUBCHEM.COMPOUND:6321415

subject_name: ceftazidime


subject: PUBCHEM.COMPOUND:6321415


subject: CHEBI:84739


subject: CHEBI:84739


subject: CHEBI:2637

subject_name: Amikacin


subject: CHEBI:2637


subject: UMLS:C1450003

subject_name: Cerazet

object_name: female infertility


subject: UMLS:C1450003

object_name: infertility


subject: CHEBI:231594

subject_name: Norgestrel


subject: CHEBI:231594


subject: PUBCHEM.COMPOUND:187888

subject_name: Endostatins

object_name: nasopharyngeal carcinoma